[{"uuid": "4b7b6182-087e-31cc-91aa-653f98e5485f", "title": "Genprex Announces First Patient Dosed in Phase 2 Expansion Portion of Acclaim-3 Clinical Study of Reqorsa\u00ae Gene Therapy in Combination with Tecentriq\u00ae to Treat Small Cell Lung Cancer", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/genprex-announces-first-patient-dosed-130000578.html", "providerPublishTime": 1737637200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ncxiwfe0apmIxaBetcSZVQ--~B/aD0xMDY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f50a341694cf7fe551faa42c59d58c55", "width": 400, "height": 106, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/juQjhD.Y.oznnh10WEDiwQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/f50a341694cf7fe551faa42c59d58c55", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GNPX"]}, {"uuid": "b80e617e-3ccb-3418-9415-ae0b6645f30c", "title": "Genprex doses first subject in expansion part of lung cancer gene therapy trial", "publisher": "Clinical Trials Arena", "link": "https://finance.yahoo.com/m/b80e617e-3ccb-3418-9415-ae0b6645f30c/genprex-doses-first-subject.html", "providerPublishTime": 1737721729, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/HuFz.3ZLHADQwuPnJMknyA--~B/aD05NjA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/clinical_trials_arena_396/1bb13d6cc629e8ae2b35d72e5ca44ca4", "width": 1440, "height": 960, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/0xhwEyX7pF519gKYaeQtcg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/clinical_trials_arena_396/1bb13d6cc629e8ae2b35d72e5ca44ca4", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GNPX"]}, {"uuid": "7fb7f353-28f3-35c5-bae9-e4265069b989", "title": "Genprex Advances Cancer Trials and Diabetes Therapy", "publisher": "TipRanks", "link": "https://finance.yahoo.com/news/genprex-advances-cancer-trials-diabetes-142822795.html", "providerPublishTime": 1736864902, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/VfFShRbSXeKd1NWnCc3B2Q--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/5c9a5f191a1b61dffcdf2f63fbd4912c", "width": 192, "height": 192, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/JpxXJhOUS620DitHw.ayrQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/5c9a5f191a1b61dffcdf2f63fbd4912c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GNPX"]}, {"uuid": "f65a951b-4f10-3c6a-8663-05cd87068b40", "title": "Genprex to Participate at the 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/genprex-participate-43rd-annual-j-141500506.html", "providerPublishTime": 1736172900, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ncxiwfe0apmIxaBetcSZVQ--~B/aD0xMDY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f50a341694cf7fe551faa42c59d58c55", "width": 400, "height": 106, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/juQjhD.Y.oznnh10WEDiwQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/f50a341694cf7fe551faa42c59d58c55", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GNPX"]}, {"uuid": "16a65236-d840-32ee-9047-08f84a83eb9f", "title": "Genprex Completes Phase 1 Dose Escalation in Trial of Reqorsa Gene Therapy to Treat Lung Cancer", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/genprex-completes-phase-1-dose-145809723.html", "providerPublishTime": 1734361089, "type": "STORY", "relatedTickers": ["GNPX"]}, {"uuid": "8d656616-63b1-3818-9128-ed4dbf4bfba5", "title": "Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa\u00ae Gene Therapy in Combination with Tecentriq\u00ae in Extensive Stage Small Cell Lung Cancer", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/genprex-receives-safety-review-committee-141500271.html", "providerPublishTime": 1734358500, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ncxiwfe0apmIxaBetcSZVQ--~B/aD0xMDY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f50a341694cf7fe551faa42c59d58c55", "width": 400, "height": 106, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/juQjhD.Y.oznnh10WEDiwQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/f50a341694cf7fe551faa42c59d58c55", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GNPX"]}, {"uuid": "c06dc6cc-98da-3c1f-8ba1-8a32d72faeee", "title": "Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/genprex-signs-exclusive-license-additional-142900288.html", "providerPublishTime": 1732112940, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ncxiwfe0apmIxaBetcSZVQ--~B/aD0xMDY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f50a341694cf7fe551faa42c59d58c55", "width": 400, "height": 106, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/juQjhD.Y.oznnh10WEDiwQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/f50a341694cf7fe551faa42c59d58c55", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GNPX"]}, {"uuid": "007f366c-b787-3c6e-8802-a6cfbb53e3d6", "title": "Genprex Signs License Deal for University of Michigan's Gene Therapy to Treat Lung Cancer", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/genprex-signs-license-deal-university-144514035.html", "providerPublishTime": 1732113914, "type": "STORY", "relatedTickers": ["GNPX"]}, {"uuid": "95f14cf7-5e80-3c1a-84ed-c0e7c5289f76", "title": "Genprex links with University of Michigan on lung cancer treatment", "publisher": "Pharmaceutical Technology", "link": "https://finance.yahoo.com/m/95f14cf7-5e80-3c1a-84ed-c0e7c5289f76/genprex-links-with-university.html", "providerPublishTime": 1732202219, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Niv_7EvGX24FeJgDM8RdOA--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/bfd084c635d7bd2ca082aae0e861e1e5", "width": 1440, "height": 810, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Jl_L5yNhe0U2vUtlqeVZRg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/bfd084c635d7bd2ca082aae0e861e1e5", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GNPX"]}]